Publications

5435 Results

Evaluation of two combination chemotherapy programs: Adriamycin and Cis-Platinum (AP) versus Adriamycin, Cis-Platinum plus VP16-213 (VAP) in the treatment of extensive squamous cell carcinoma of the lung. A Southwest Oncology Group study. Phase III (preliminary data).

Authors
PN Grozea;B Hom;TT Chen;JJ Costanzi;SP Balcerzak;RM O'Bryan;M Lane;RL Stephens;SC Dodd-Taylor;RB Livingston
Journal / Conference
In: 13th International Congress of Chemotherapy (Vienna, August 28-September 2).
Year
1983
Research Committee(s)
Lung
Study Number(s)
SWOG-8015

Long-term survivors with small-cell lung cancer (SCLC): A Southwest Oncology Group (SWOG) study.

Authors
RB Livingston
Journal / Conference
ASCO, #C-730
Year
1983
Research Committee(s)
Lung
Study Number(s)
SWOG-7415/A

Outcome of prophylactic and therapeutic cranial irradiation in disseminated small lung carcinoma. A Southwest Oncology Group study.

Authors
JG Mira;TT Chen;RB Livingston;SP Balcerzak
Journal / Conference
IASLC Workshop on Radiotherapy for Lung Cancer (Cambridge, England, July)
Year
1983
Research Committee(s)
Lung
Study Number(s)
SWOG-7828

Alternating combination chemotherapy prolongs survival for metastatic non-small cell lung cancer (NSCLC) (for the Southwest Oncology Group).

Authors
TP Miller;TT Chen
Journal / Conference
ASCO, #C-733
Year
1983
Research Committee(s)
Lung
Study Number(s)
SWOG-8012

Comparison of Adriamycin-containing chemotherapy (MOP- BAP) with MOPP-Bleomycin in the management of advanced Hodgkin's disease. A Southwest Oncology Group study

Authors
SE Jones;A Haut;JK Weick;HE Wilson;P Grozea;CJ Fabian;E McKelvey;GE Byrne Jr;R Hartsock;DO Dixon;CA Coltman Jr
Journal / Conference
Cancer 51:1339-1347
Year
1983
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-7406

Combined modality treatment of advanced Hodgkin's disease: Southwest Oncology Group studies In:

Authors
CA Coltman Jr;E Frei III;E Montague;PN Grozea;EJ DePersio;CJ Fabian;CM Mansfield;SE Jones;DO Dixon
Journal / Conference
In: Management of Advanced Cancer P Periman, E Savlov eds. Masson Publishing USA 79-111
Year
1983
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-7406, SWOG-7518

Improved complete remission rates and survival for patients with large cell lymphoma treated with chemoimmunotherapy. A Southwest Oncology Group study

Authors
SE Jones;PN Grozea;EN Metz;A Haut;RL Stephens;FS Morrison;R Talley;JJ Butler;GE Byrne;R Hartsock;D Dixon;SE Salmon
Journal / Conference
Cancer 51:1083-1090
Year
1983
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-7426/7427

The combined modality therapy of diffuse histology non- Hodgkin's lymphoma with cyclophosphamide, adriamycin, vincristine, prednisone (CHOP) and total body irradiation

Authors
JK Weick;A Antunez;TA Kraus;CJ Fabian;D Dixon
Journal / Conference
Int J Rad Oncol Biol Phys 9:1205-1207
Year
1983
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-7761

Methyl-glyoxal bis guanyl hydrazone (Methyl-GAG, MGBG) in lymphoma and Hodgkin's disease. A Phase II trial of the Southwest Oncology Group

Authors
WA Knight III;C Fabian;JJ Costanzi;SE Jones;CA Coltman Jr
Journal / Conference
Investigational New Drugs 1:235-237
Year
1983
Research Committee(s)
Multiple sites
Study Number(s)
SWOG-7860

Gallium Nitrate in malignant lymphoma: A Southwest Oncology Group study

Authors
JK Weick;RL Stephens;LH Baker;SE Jones
Journal / Conference
Cancer Treat Rep 67:823-825
Year
1983
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-7912